CVD

ThermVac to Expand Ceramic CVD Equipment Presence in China

Thursday, January 14, 2021 - 3:25am

In 2011, ThermVac took its first step in the world of ceramic CVD equipment by performing the localization development project of SiC CVD pilot equipment in the Korean government's technology development support project.

Key Points: 
  • In 2011, ThermVac took its first step in the world of ceramic CVD equipment by performing the localization development project of SiC CVD pilot equipment in the Korean government's technology development support project.
  • During the two-year project period, ThermVac successfully carried out the development project while faithfully securing the elemental technology of the CVD equipment.
  • Based on its performance in Korea, ThermVac entered the Chinese market, exporting a large SiC CVD equipment with a work zone of 1200*1800H mm to Company A in Jiangsu Province in 2017 and then delivered TaC CVD equipment to Company T in Xuzhou Province this time.
  • ThermVac is accumulating ceramic CVD process technology of its own through the in-house 2400C pilot CVD equipment while focusing on the larger market such as China or Japan beyond the small domestic market and plans to expand the supply of CVD equipment by competing with western CVD furnace brands in earnest.

How Remote Patient Monitoring is Improving Cardiovascular Disease Patient Outcomes, Reports IDTechEx

Monday, December 14, 2020 - 5:49pm

The IDTechEx market research report " Cardiovascular Disease 2020-2030: Trends, Technologies & Outlook " examines emerging technologies for diagnosis, remote monitoring, and treatment.

Key Points: 
  • The IDTechEx market research report " Cardiovascular Disease 2020-2030: Trends, Technologies & Outlook " examines emerging technologies for diagnosis, remote monitoring, and treatment.
  • The biggest trends in CVD management currently revolve around remote patient monitoring (RPM), which enables the patients' health to be examined from a distance.
  • These applications include improving patient adherence, clinical trial monitoring, pre/post-op monitoring, and predicting/preventing cardiac events.
  • For more information on the IDTechEx report " Cardiovascular Disease 2020-2030: Trends, Technologies & Outlook ", please visit www.IDTechEx.com/CVD or for the full portfolio ofHealthcareresearch available from IDTechEx please visit www.IDTechEx.com/Research/Healthcare .

How Remote Patient Monitoring is Improving Cardiovascular Disease Patient Outcomes, Reports IDTechEx

Monday, December 14, 2020 - 5:45pm

The IDTechEx market research report " Cardiovascular Disease 2020-2030: Trends, Technologies & Outlook " examines emerging technologies for diagnosis, remote monitoring, and treatment.

Key Points: 
  • The IDTechEx market research report " Cardiovascular Disease 2020-2030: Trends, Technologies & Outlook " examines emerging technologies for diagnosis, remote monitoring, and treatment.
  • The biggest trends in CVD management currently revolve around remote patient monitoring (RPM), which enables the patients' health to be examined from a distance.
  • These applications include improving patient adherence, clinical trial monitoring, pre/post-op monitoring, and predicting/preventing cardiac events.
  • For more information on the IDTechEx report " Cardiovascular Disease 2020-2030: Trends, Technologies & Outlook ", please visit www.IDTechEx.com/CVD or for the full portfolio ofHealthcareresearch available from IDTechEx please visit www.IDTechEx.com/Research/Healthcare .

From Promise to Reality: MyoKardia and Medpace Talk Precision Medicine in Cardiovascular Disease, Upcoming Webinar Hosted by Xtalks

Monday, November 30, 2020 - 1:30pm

Recently, breakthroughs in precision medicine are creating optimism for a field that has historically witnessed few long-term successes in targeted therapeutic approaches.

Key Points: 
  • Recently, breakthroughs in precision medicine are creating optimism for a field that has historically witnessed few long-term successes in targeted therapeutic approaches.
  • By matching mechanism of a drug action with specific disease etiology, precision-medicine approaches are starting to turn the page in CVD trials.
  • Join experts from Medpace and MyoKardia in a live webinar on Tuesday, December 15, 2020 at 12pm EST (5pm GMT/UK).
  • For more information, or to register for this event, visit From Promise to Reality: MyoKardia and Medpace Talk Precision Medicine in Cardiovascular Disease.

Eyelit’s Integrated Manufacturing System (MES) Selected and Deployed by WD Lab Grown Diamonds

Wednesday, November 18, 2020 - 5:02pm

Eyelit Inc., a manufacturing software provider for visibility, control, and coordination of manufacturing operations, announced today that WD Lab Grown Diamonds, the leading U.S. producer of Chemical Vapor Deposition (CVD) lab grown diamonds, has implemented Eyelits MES Software Suite at its headquarters near Washington, D.C.

Key Points: 
  • Eyelit Inc., a manufacturing software provider for visibility, control, and coordination of manufacturing operations, announced today that WD Lab Grown Diamonds, the leading U.S. producer of Chemical Vapor Deposition (CVD) lab grown diamonds, has implemented Eyelits MES Software Suite at its headquarters near Washington, D.C.
    WD Lab Grown Diamonds has deployed Eyelits cost-effective software to support mixed mode manufacturing processes, which include hybrid fabrication methods.
  • We selected and implemented Eyelits software for its ability to handle both semiconductor and industrial type manufacturing, as well as the flexible subscription licensing model, stated Yarden Tsach, CTO of WD Lab Grown Diamonds.
  • Eyelit came highly recommended to WD Lab Grown Diamonds; its software provides extensive capabilities to sustain our companys rapid growth and meets our evolving needs.
  • WD Lab Grown Diamonds is the exclusive licensee of a portfolio of patents covering single crystal CVD diamond growth technology developed by The Carnegie Institution of Washington.

Bayer Presents FIDELIO-DKD Phase III Study Cardiovascular Subgroup Analysis of Patients With Chronic Kidney Disease and Type 2 Diabetes

Tuesday, November 17, 2020 - 11:00am

In this pre-specified exploratory subgroup analysis of FIDELIO-DKD study of finerenone, researchers evaluated the secondary composite CV outcomes by patient history of CVD (Interaction p-0.85).

Key Points: 
  • In this pre-specified exploratory subgroup analysis of FIDELIO-DKD study of finerenone, researchers evaluated the secondary composite CV outcomes by patient history of CVD (Interaction p-0.85).
  • These findings underscore the life-threatening connection between chronic kidney disease and cardiovascular disease.
  • Phase III data from the FIDELIO-DKD study were presented in October at the American Society of Nephrologys (ASN) Kidney Week 2020, and simultaneously published in the New England Journal of Medicine.
  • Based on these data, Bayer submitted applications for marketing authorization of finerenone in the U.S. and the EU.

USW Commends Commerce Department's Preliminary Duty Determination on Vietnamese Tires

Wednesday, November 4, 2020 - 8:51pm

PITTSBURGH, Nov. 4, 2020 /PRNewswire/ -- The United Steelworkers (USW) today praised U.S. Department of Commerce's affirmative preliminary determination in the countervailing duty (CVD) investigation of passenger vehicle and light truck (passenger tires) tires imported from Vietnam.

Key Points: 
  • PITTSBURGH, Nov. 4, 2020 /PRNewswire/ -- The United Steelworkers (USW) today praised U.S. Department of Commerce's affirmative preliminary determination in the countervailing duty (CVD) investigation of passenger vehicle and light truck (passenger tires) tires imported from Vietnam.
  • The decision resulted from a petition filed by the USW to address unfairly traded imports of tires.
  • USW International President Thomas M. Conway applauded the determination and called for continued vigilance against unfair and illegal trade practices.
  • In addition to its CVD actions on Vietnamese tires, the Department of Commerce is concurrently conducting antidumping duty (AD) investigations of passenger tires from Korea, Taiwan, Thailand, and Vietnam, with preliminary determinations scheduled to be announced on December 29, 2020.

WD Lab Grown Diamonds Announces CVD Patent Sublicensing Agreements with Select Industry Partners

Thursday, October 22, 2020 - 4:00pm

WASHINGTON, Oct. 22, 2020 /PRNewswire/ --M7D Corporation d/b/a WD Lab Grown Diamonds ("WD"), the pioneering producer of chemical vapor deposition (CVD) laboratory grown diamonds, today announced that it has entered into patent sublicensing agreements with ALTR (India) Private Limited and ALTR, Inc. ("ALTR") and Evolution Diamond ("Evolution").

Key Points: 
  • WASHINGTON, Oct. 22, 2020 /PRNewswire/ --M7D Corporation d/b/a WD Lab Grown Diamonds ("WD"), the pioneering producer of chemical vapor deposition (CVD) laboratory grown diamonds, today announced that it has entered into patent sublicensing agreements with ALTR (India) Private Limited and ALTR, Inc. ("ALTR") and Evolution Diamond ("Evolution").
  • The agreements, the first of their kind in the industry, permit both entities to distribute CVD lab grown diamonds, whether grown by WD or other approved manufacturers, in the United States, Canada, Mexico and all other global territories where the patents are in force.
  • "We are pleased to bring these global partners and leaders in as the first sublicensees of WD's ground-breaking technology," said Sue Rechner, Chief Executive Officer of WD Lab Grown Diamonds.
  • WD Lab Grown Diamonds is the exclusive licensee of a portfolio of patents covering single crystal CVD diamond growth technology developed by The Carnegie Institution of Washington.

ITC Votes Unanimously in Support of Domestic Staple Industry; Chinese Collated Staple Imports Now Subject to Combined AD/CVD Duties Over 300%

Tuesday, June 23, 2020 - 8:25pm

With today's vote, the Department of Commerce (Commerce) will issue antidumping (AD) and countervailing duty (CVD) orders in the coming days.

Key Points: 
  • With today's vote, the Department of Commerce (Commerce) will issue antidumping (AD) and countervailing duty (CVD) orders in the coming days.
  • Senco petitioned Commerce and the ITC to investigate certain collated staple imports from China in July 2019.
  • In 2018, U.S. imports of certain collated staples from China were valued at an estimated $88.8 million, according to Commerce.
  • "Thanks to the support of Commerce and the ITC, it looks like we are going to get the chance to do that again.

CRU: European Aluminium Rollers in the Eye of the Storm Caused by Another US Dumping Investigation

Friday, June 19, 2020 - 9:00am

This comes only 13 months after the US Department of Commerce published AD and CVD orders on imports of common alloy sheet from China.

Key Points: 
  • This comes only 13 months after the US Department of Commerce published AD and CVD orders on imports of common alloy sheet from China.
  • Domestic producers also filed countervailing duty petitions alleging that producers in Bahrain, Brazil, India, and Turkey benefit from numerous government subsidy programs."
  • Just like the China case, excluded from the scope of the latest petition is aluminium can stock.
  • In the immediate aftermath of the China investigation being announced, imports from China surged ahead of the preliminary duties being issued.